UniProt ID | M3K1_HUMAN | |
---|---|---|
UniProt AC | Q13233 | |
Protein Name | Mitogen-activated protein kinase kinase kinase 1 | |
Gene Name | MAP3K1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1512 | |
Subcellular Localization | ||
Protein Description | Component of a protein kinase signal transduction cascade. [PubMed: 9808624 Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4] | |
Protein Sequence | MAAAAGNRASSSGFPGARATSPEAGGGGGALKASSAPAAAAGLLREAGSGGRERADWRRRQLRKVRSVELDQLPEQPLFLAASPPASSTSPSPEPADAAGSGTGFQPVAVPPPHGAASRGGAHLTESVAAPDSGASSPAAAEPGEKRAPAAEPSPAAAPAGREMENKETLKGLHKMDDRPEERMIREKLKATCMPAWKHEWLERRNRRGPVVVKPIPVKGDGSEMNHLAAESPGEVQASAASPASKGRRSPSPGNSPSGRTVKSESPGVRRKRVSPVPFQSGRITPPRRAPSPDGFSPYSPEETNRRVNKVMRARLYLLQQIGPNSFLIGGDSPDNKYRVFIGPQNCSCARGTFCIHLLFVMLRVFQLEPSDPMLWRKTLKNFEVESLFQKYHSRRSSRIKAPSRNTIQKFVSRMSNSHTLSSSSTSTSSSENSIKDEEEQMCPICLLGMLDEESLTVCEDGCRNKLHHHCMSIWAEECRRNREPLICPLCRSKWRSHDFYSHELSSPVDSPSSLRAAQQQTVQQQPLAGSRRNQESNFNLTHYGTQQIPPAYKDLAEPWIQVFGMELVGCLFSRNWNVREMALRRLSHDVSGALLLANGESTGNSGGSSGSSPSGGATSGSSQTSISGDVVEACCSVLSMVCADPVYKVYVAALKTLRAMLVYTPCHSLAERIKLQRLLQPVVDTILVKCADANSRTSQLSISTLLELCKGQAGELAVGREILKAGSIGIGGVDYVLNCILGNQTESNNWQELLGRLCLIDRLLLEFPAEFYPHIVSTDVSQAEPVEIRYKKLLSLLTFALQSIDNSHSMVGKLSRRIYLSSARMVTTVPHVFSKLLEMLSVSSSTHFTRMRRRLMAIADEVEIAEAIQLGVEDTLDGQQDSFLQASVPNNYLETTENSSPECTVHLEKTGKGLCATKLSASSEDISERLASISVGPSSSTTTTTTTTEQPKPMVQTKGRPHSQCLNSSPLSHHSQLMFPALSTPSSSTPSVPAGTATDVSKHRLQGFIPCRIPSASPQTQRKFSLQFHRNCPENKDSDKLSPVFTQSRPLPSSNIHRPKPSRPTPGNTSKQGDPSKNSMTLDLNSSSKCDDSFGCSSNSSNAVIPSDETVFTPVEEKCRLDVNTELNSSIEDLLEASMPSSDTTVTFKSEVAVLSPEKAENDDTYKDDVNHNQKCKEKMEAEEEEALAIAMAMSASQDALPIVPQLQVENGEDIIIIQQDTPETLPGHTKAKQPYREDTEWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMSHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVALRCLELQPQDRPPSRELLKHPVFRTTW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAAGNRA ------CCCCCCCCC | 19.67 | 19413330 | |
11 | Phosphorylation | AAGNRASSSGFPGAR CCCCCCCCCCCCCCC | 33.23 | 24173317 | |
12 | Phosphorylation | AGNRASSSGFPGARA CCCCCCCCCCCCCCC | 41.79 | 24173317 | |
20 | Phosphorylation | GFPGARATSPEAGGG CCCCCCCCCCCCCCC | 38.98 | 23401153 | |
21 | Phosphorylation | FPGARATSPEAGGGG CCCCCCCCCCCCCCC | 21.54 | 23401153 | |
34 | Phosphorylation | GGGALKASSAPAAAA CCCCCCCCCHHHHHH | 25.99 | 28450419 | |
35 | Phosphorylation | GGALKASSAPAAAAG CCCCCCCCHHHHHHH | 43.03 | 21082442 | |
67 | Phosphorylation | RQLRKVRSVELDQLP HHHHHHHCEEHHHCC | 23.96 | 22817900 | |
83 | Phosphorylation | QPLFLAASPPASSTS CCEEEEECCCCCCCC | 26.30 | 25921289 | |
92 | Phosphorylation | PASSTSPSPEPADAA CCCCCCCCCCCCCCC | 41.48 | 25921289 | |
133 | Phosphorylation | ESVAAPDSGASSPAA CCCCCCCCCCCCCCC | 34.89 | 25159151 | |
136 | Phosphorylation | AAPDSGASSPAAAEP CCCCCCCCCCCCCCC | 40.14 | 25159151 | |
137 | Phosphorylation | APDSGASSPAAAEPG CCCCCCCCCCCCCCC | 20.30 | 25159151 | |
154 | Phosphorylation | RAPAAEPSPAAAPAG CCCCCCCCCCCCCCC | 20.76 | 25159151 | |
169 | Phosphorylation | REMENKETLKGLHKM CCCCCHHHHHHHHCC | 35.07 | 18767875 | |
223 | Phosphorylation | IPVKGDGSEMNHLAA EECCCCCHHHCCCCC | 38.11 | 27732954 | |
232 | Phosphorylation | MNHLAAESPGEVQAS HCCCCCCCCCCCCCC | 33.22 | 25159151 | |
239 | Phosphorylation | SPGEVQASAASPASK CCCCCCCCCCCCCCC | 13.79 | 22199227 | |
242 | Phosphorylation | EVQASAASPASKGRR CCCCCCCCCCCCCCC | 22.25 | 25159151 | |
245 | Phosphorylation | ASAASPASKGRRSPS CCCCCCCCCCCCCCC | 38.74 | 27732954 | |
250 | Phosphorylation | PASKGRRSPSPGNSP CCCCCCCCCCCCCCC | 28.50 | 27794612 | |
252 | Phosphorylation | SKGRRSPSPGNSPSG CCCCCCCCCCCCCCC | 46.84 | 27794612 | |
256 | Phosphorylation | RSPSPGNSPSGRTVK CCCCCCCCCCCCCCC | 26.76 | 30576142 | |
258 | Phosphorylation | PSPGNSPSGRTVKSE CCCCCCCCCCCCCCC | 40.50 | 30576142 | |
264 | Phosphorylation | PSGRTVKSESPGVRR CCCCCCCCCCCCCCC | 38.68 | 25159151 | |
266 | Phosphorylation | GRTVKSESPGVRRKR CCCCCCCCCCCCCCC | 33.76 | 25850435 | |
275 | Phosphorylation | GVRRKRVSPVPFQSG CCCCCCCCCCCCCCC | 24.98 | 30266825 | |
281 | Phosphorylation | VSPVPFQSGRITPPR CCCCCCCCCCCCCCC | 30.34 | 23403867 | |
285 | Phosphorylation | PFQSGRITPPRRAPS CCCCCCCCCCCCCCC | 26.36 | 23403867 | |
292 | Phosphorylation | TPPRRAPSPDGFSPY CCCCCCCCCCCCCCC | 34.34 | 23401153 | |
297 | O-linked_Glycosylation | APSPDGFSPYSPEET CCCCCCCCCCCHHHH | 28.58 | 29351928 | |
297 | Phosphorylation | APSPDGFSPYSPEET CCCCCCCCCCCHHHH | 28.58 | 30266825 | |
299 | Phosphorylation | SPDGFSPYSPEETNR CCCCCCCCCHHHHHH | 35.34 | 28450419 | |
300 | Phosphorylation | PDGFSPYSPEETNRR CCCCCCCCHHHHHHH | 29.26 | 25159151 | |
304 | Phosphorylation | SPYSPEETNRRVNKV CCCCHHHHHHHHHHH | 32.15 | 25850435 | |
317 | Phosphorylation | KVMRARLYLLQQIGP HHHHHHHHHHHHHCC | 10.38 | 24300666 | |
326 | Phosphorylation | LQQIGPNSFLIGGDS HHHHCCCCEECCCCC | 25.27 | 24300666 | |
333 | Phosphorylation | SFLIGGDSPDNKYRV CEECCCCCCCCCEEE | 37.11 | 24300666 | |
338 | Phosphorylation | GDSPDNKYRVFIGPQ CCCCCCCEEEEECCC | 20.47 | 24300666 | |
391 | Ubiquitination | EVESLFQKYHSRRSS CHHHHHHHHHHCCCC | 37.28 | 29967540 | |
397 | Phosphorylation | QKYHSRRSSRIKAPS HHHHHCCCCCCCCCC | 23.90 | 24719451 | |
398 | Phosphorylation | KYHSRRSSRIKAPSR HHHHCCCCCCCCCCH | 35.89 | 24719451 | |
431 | Phosphorylation | SSTSTSSSENSIKDE CCCCCCCCCCCCCHH | 40.33 | - | |
436 | Sumoylation | SSSENSIKDEEEQMC CCCCCCCCHHHHHHC | 59.93 | - | |
436 | Sumoylation | SSSENSIKDEEEQMC CCCCCCCCHHHHHHC | 59.93 | - | |
497 | Phosphorylation | LCRSKWRSHDFYSHE HHCCCCCCCCCCCCC | 26.71 | 23186163 | |
501 | Phosphorylation | KWRSHDFYSHELSSP CCCCCCCCCCCCCCC | 18.38 | 28450419 | |
502 | Phosphorylation | WRSHDFYSHELSSPV CCCCCCCCCCCCCCC | 15.52 | 28450419 | |
506 | Phosphorylation | DFYSHELSSPVDSPS CCCCCCCCCCCCCHH | 29.61 | 21712546 | |
507 | Phosphorylation | FYSHELSSPVDSPSS CCCCCCCCCCCCHHH | 41.38 | 25159151 | |
511 | Phosphorylation | ELSSPVDSPSSLRAA CCCCCCCCHHHHHHH | 27.24 | 25159151 | |
513 | Phosphorylation | SSPVDSPSSLRAAQQ CCCCCCHHHHHHHHH | 46.05 | 28450419 | |
514 | Phosphorylation | SPVDSPSSLRAAQQQ CCCCCHHHHHHHHHH | 25.84 | 23663014 | |
522 | Phosphorylation | LRAAQQQTVQQQPLA HHHHHHHHHHHCCCC | 18.88 | 22210691 | |
531 | Phosphorylation | QQQPLAGSRRNQESN HHCCCCCCCCCCCCC | 23.59 | 26434776 | |
542 | Phosphorylation | QESNFNLTHYGTQQI CCCCCCCCCCCCCCC | 17.73 | - | |
657 | Phosphorylation | VYVAALKTLRAMLVY HHHHHHHHHHHHHHH | 23.48 | 22817900 | |
665 | Phosphorylation | LRAMLVYTPCHSLAE HHHHHHHCCCCHHHH | 16.38 | 22817900 | |
686 | Phosphorylation | LLQPVVDTILVKCAD HHHHHCHHHHHECCC | 12.47 | 22964224 | |
690 | Ubiquitination | VVDTILVKCADANSR HCHHHHHECCCCCCH | 21.91 | - | |
796 | Phosphorylation | IRYKKLLSLLTFALQ HHHHHHHHHHHHHHH | 31.59 | - | |
829 | Phosphorylation | SSARMVTTVPHVFSK HCCCHHHCHHHHHHH | 22.19 | 30576142 | |
844 | Phosphorylation | LLEMLSVSSSTHFTR HHHHHCCCCCHHHHH | 18.39 | - | |
850 | Phosphorylation | VSSSTHFTRMRRRLM CCCCHHHHHHHHHHH | 18.89 | - | |
919 | Ubiquitination | GKGLCATKLSASSED CCCEEEEECCCCCCH | 23.17 | 29967540 | |
921 | Phosphorylation | GLCATKLSASSEDIS CEEEEECCCCCCHHH | 27.88 | 23927012 | |
923 | Phosphorylation | CATKLSASSEDISER EEEECCCCCCHHHHH | 30.77 | 19664994 | |
924 | Phosphorylation | ATKLSASSEDISERL EEECCCCCCHHHHHH | 38.72 | 29255136 | |
928 | Phosphorylation | SASSEDISERLASIS CCCCCHHHHHHHHCE | 29.05 | 23403867 | |
999 | Phosphorylation | SVPAGTATDVSKHRL CCCCCCCCCCHHHHH | 36.45 | - | |
1013 | Ubiquitination | LQGFIPCRIPSASPQ HCCCCCEECCCCCHH | 38.20 | 21963094 | |
1015 | Ubiquitination | GFIPCRIPSASPQTQ CCCCEECCCCCHHHH | 12.42 | 22817900 | |
1016 | Phosphorylation | FIPCRIPSASPQTQR CCCEECCCCCHHHHH | 38.72 | 21082442 | |
1017 | Ubiquitination | IPCRIPSASPQTQRK CCEECCCCCHHHHHH | 21.63 | 22817900 | |
1018 | Phosphorylation | PCRIPSASPQTQRKF CEECCCCCHHHHHHE | 23.13 | 29255136 | |
1021 | Phosphorylation | IPSASPQTQRKFSLQ CCCCCHHHHHHEEEE | 33.45 | 28450419 | |
1026 | Phosphorylation | PQTQRKFSLQFHRNC HHHHHHEEEEEHHCC | 25.05 | 28152594 | |
1039 | Phosphorylation | NCPENKDSDKLSPVF CCCCCCCCCCCCCCC | 37.95 | 29449344 | |
1039 | Ubiquitination | NCPENKDSDKLSPVF CCCCCCCCCCCCCCC | 37.95 | 21963094 | |
1041 | Ubiquitination | PENKDSDKLSPVFTQ CCCCCCCCCCCCCCC | 55.61 | 22817900 | |
1043 | Phosphorylation | NKDSDKLSPVFTQSR CCCCCCCCCCCCCCC | 25.43 | 25849741 | |
1043 | Ubiquitination | NKDSDKLSPVFTQSR CCCCCCCCCCCCCCC | 25.43 | 22817900 | |
1047 | Phosphorylation | DKLSPVFTQSRPLPS CCCCCCCCCCCCCCC | 26.35 | 27732954 | |
1080 | Phosphorylation | QGDPSKNSMTLDLNS CCCCCCCCEEEECCC | 19.51 | 22210691 | |
1082 | Phosphorylation | DPSKNSMTLDLNSSS CCCCCCEEEECCCCC | 19.55 | 28857561 | |
1087 | Phosphorylation | SMTLDLNSSSKCDDS CEEEECCCCCCCCCC | 43.20 | 18691976 | |
1088 | Phosphorylation | MTLDLNSSSKCDDSF EEEECCCCCCCCCCC | 32.51 | 25627689 | |
1089 | Phosphorylation | TLDLNSSSKCDDSFG EEECCCCCCCCCCCC | 36.80 | - | |
1114 | Phosphorylation | PSDETVFTPVEEKCR CCCCCEECCCHHHHC | 23.30 | 27251275 | |
1157 | Phosphorylation | KSEVAVLSPEKAEND EEEEEEECHHHCCCC | 25.14 | 25159151 | |
1160 | Ubiquitination | VAVLSPEKAENDDTY EEEECHHHCCCCCCC | 65.47 | 33845483 | |
1166 | Phosphorylation | EKAENDDTYKDDVNH HHCCCCCCCHHCCCH | 35.02 | 27732954 | |
1167 | Phosphorylation | KAENDDTYKDDVNHN HCCCCCCCHHCCCHH | 21.29 | 27732954 | |
1168 | Ubiquitination | AENDDTYKDDVNHNQ CCCCCCCHHCCCHHH | 49.93 | - | |
1176 | Ubiquitination | DDVNHNQKCKEKMEA HCCCHHHHHHHHHHH | 53.22 | 21963094 | |
1178 | Ubiquitination | VNHNQKCKEKMEAEE CCHHHHHHHHHHHHH | 68.36 | 22817900 | |
1180 | Ubiquitination | HNQKCKEKMEAEEEE HHHHHHHHHHHHHHH | 27.77 | 22817900 | |
1235 | Ubiquitination | PGHTKAKQPYREDTE CCCCCCCCCCCCCCH | 45.15 | 22053931 | |
1261 | Ubiquitination | FSSCYQAQDVGTGTL CCCCEEEECCCCCCE | 30.32 | 22053931 | |
1338 | Phosphorylation | VAHLLSKYGAFKESV HHHHHHHCCCCCCEE | 15.43 | - | |
1371 | Ubiquitination | QIIHRDVKGANLLID CEECCCCCCCCEEEC | 57.50 | - | |
1379 | Phosphorylation | GANLLIDSTGQRLRI CCCEEECCCCCEEEE | 27.69 | 27174698 | |
1380 | Phosphorylation | ANLLIDSTGQRLRIA CCEEECCCCCEEEEH | 33.32 | 27174698 | |
1397 | Phosphorylation | GAAARLASKGTGAGE HHHHHHHHCCCCCHH | 35.89 | 27251275 | |
1398 | Ubiquitination | AAARLASKGTGAGEF HHHHHHHCCCCCHHH | 55.68 | 21906983 | |
1400 | Phosphorylation | ARLASKGTGAGEFQG HHHHHCCCCCHHHHH | 27.82 | 27251275 | |
1412 | Phosphorylation | FQGQLLGTIAFMAPE HHHHHHHHHHHHCHH | 14.76 | - | |
1455 | Phosphorylation | PWNAEKHSNHLALIF CCCCCCCCCHHHHHH | 36.69 | 25850435 | |
1504 | Ubiquitination | PPSRELLKHPVFRTT CCCHHHHCCCCCCCC | 59.49 | 32015554 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of M3K1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M3K1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
613762 | 46,XY sex reversal 6 (SRXY6) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-21 AND SER-923, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-21; SER-35;SER-133; SER-136; SER-252; SER-275; SER-292; SER-507; SER-923;SER-1016; SER-1018 AND SER-1157, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-21 AND SER-923, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292; SER-297; SER-300;SER-507; SER-511 AND SER-1018, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-35; SER-154;SER-232; SER-242; SER-292; SER-297; SER-300; SER-507; SER-511;SER-923; SER-1018; SER-1043 AND SER-1157, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-657 AND THR-665, ANDMASS SPECTROMETRY. |